Q0ED31 (Q0ED31_HV1) Human immunodeficiency virus type 1 (HIV-1)
Envelope glycoprotein gp160 UniProtKBInterProInteractive Modelling
857 aa; Sequence (Fasta)
It is possible new templates exist for this target since these models were created.
Available Structures
36 Experimental Structures
| Description | PDB ID | Oligo-state | Range | Seq id (%) | Ligands | |
|---|---|---|---|---|---|---|
| Crystal structure of HIV-1 93TH057 coreE gp120 with antibody 45-VRC01.H01+07.O-863513/45-VRC01.L01+… |
Heteromer | 100 | 11×NAG; | |||
| Crystal structure of broadly and potently neutralizing antibody C38-VRC18.02 in complex with HIV-1 … |
Heteromer | 100 | 11×NAG; 1×EPE; 1×SO4; | |||
| Crystal structure of non-neutralizing and ADCC-potent antibody N5-i5 in complex with HIV-1 clade A/… |
Heteromer P01730; | 100 | 10×NAG; 3×MRD; 1×GOL; | |||
| Crystal structure of broadly and potently neutralizing antibody VRC03 in complex with HIV-1 gp120 |
Heteromer | 100 | 11×NAG; 8×SO4; 2×EDO; 1×TRS; | |||
| Crystal structure of broadly and potently neutralizing antibody VRC-PG04 in complex with HIV-1 gp120 |
Heteromer | 100 | 10×NAG; 5×SO4; 4×GOL; 18×CL; 1×BU3; 1×TRS; | |||
| Crystal structure of antibody VRC07-G54W in complex with clade A/E 93TH057 HIV-1 gp120 core |
Heteromer | 100 | 10×NAG; | |||
| Crystal structure of antibody VRC07-I30Q, G54W, S58N in complex with clade A/E 93TH057 HIV-1 gp120 … |
Heteromer | 100 | 10×NAG; | |||
| Crystal structure of broadly and potently neutralizing antibody VRC-CH31 in complex with HIV-1 clad… |
Heteromer | 100 | 1×NAG; 12×NAG; 3×SO4; 11×EDO; 2×PEG; 3×NA; | |||
| Crystal structure of antibody VRC07-G54L in complex with clade A/E 93TH057 HIV-1 gp120 core |
Heteromer | 100 | 8×NAG; | |||
| Crystal structure of antibody VRC07 in complex with clade A/E 93TH057 HIV-1 gp120 core |
Heteromer | 100 | 10×NAG; | |||
| Crystal structure of broadly and potently neutralizing antibody VRC-CH31 in complex with HIV-1 clad… |
Heteromer | 100 | 9×NAG; 5×CD; 1×BU3; 3×CL; 4×NA; | |||
| Crystal structure of antibody VRC07-G54Y in complex with clade A/E 93TH057 HIV-1 gp120 core |
Heteromer | 100 | 10×NAG; | |||
| Crystal structure of broadly and potently neutralizing antibody VRC-PG20 in complex with HIV-1 clad… |
Heteromer | 100 | 10×NAG; 1×EPE; 5×EDO; 1×CL; | |||
| Crystal structure of antibody VRC07-G54R in complex with clade A/E 93TH057 HIV-1 gp120 core |
Heteromer | 100 | 10×NAG; | |||
| Crystal structure of antibody VRC07-G54F in complex with clade A/E 93TH057 HIV-1 gp120 core |
Heteromer | 100 | 11×NAG; | |||
| Crystal structure of antibody VRC06 in complex with HIV-1 gp120 core |
Heteromer | 100 | 10×NAG; | |||
| Crystal structure of broadly and potently neutralizing antibody VRC01 in complex with HIV-1 gp120 |
Heteromer | 100 | 1×NAG; 11×NAG; 1×BGC; | |||
| Crystal structure of antibody VRC07-G54H in complex with clade A/E 93TH057 HIV-1 gp120 core |
Heteromer | 100 | 10×NAG; | |||
| Restricting HIV-1 Pathways for Escape using Rationally-Designed Anti-HIV-1 Antibodies |
Heteromer | 97.5 | 1×NAG; 1×NAG; 1×NAG; 5×NAG; | |||
| Crystal structure of broadly and potently neutralizing antibody 3bnc117 in complex with hiv-1 gp120 |
Heteromer | 100 | 11×NAG; 1×EPE; 4×EDO; | |||
| Crystal structure of broadly and potently neutralizing antibody 12a21 in complex with hiv-1 strain … |
Heteromer | 100 | 10×NAG; 1×EPE; | |||
| Crystal structure of the ADCC-Potent Antibody N60-I3 Fab in complex with HIV-1 Clade A/E gp120 and … |
Heteromer | 100 | 9×NAG; | |||
| Crystal structure of ADCC-potent Rhesus macaque ANTIBODY JR4 in complex with HIV-1 CLADE A/E GP120 … |
Heteromer | 100 | 9×NAG; | |||
| Crystal structure of VH1-46 germline-derived CD4-binding site-directed antibody 1B2530 in complex w… |
Heteromer | 100 | 6×NAG; | |||
| Crystal structure of broadly and potently neutralizing antibody VRC06B in complex with HIV-1 clade … |
Heteromer P01834; P01857; | 100 | 1×NAG; 6×NAG; | |||
| Crystal structure of broadly and potently neutralizing antibody C38-VRC16.01 in complex with HIV-1 … |
Heteromer | 100 | 10×NAG; 7×PEG; 13×GOL; 1×NHE; | |||
| Crystal structure of broadly and potently neutralizing antibody VRC-CH31 in complex with HIV-1 clad… |
Heteromer | 100 | 9×NAG; 5×SO4; | |||
| Crystal structure of broadly and potently neutralizing antibody 44-VRC13.01 in complex with HIV-1 c… |
Heteromer | 100.0 | 11×NAG; 2×IPA; 1×BU3; 1×NA; | |||
| Crystal structure of chimeric germ-line precursor of NIH45-46 Fab in complex with gp120 of 93TH057 … |
Heteromer | 97.5 | 1×SO4; 1×NAG; | |||
| Crystal structure of 8ANC195 Fab in complex with gp120 of 93TH057 HIV-1 and soluble CD4 D1D2 |
Heteromer P01730; | 96.25 | 2×NAG; 1×NAG; 2×NAG; 1×NAG; 1×EPE; 2×BEN; 3×NAG; | |||
| Crystal structure of clade A/E 93TH057 HIV-1 gp120 core in complex with AWS-I-50 | monomer | 100 | 11×NAG; 1×EPE; 1×0LL; | |||
| Crystal structure of clade A/E 93TH057 HIV-1 gp120 core in complex with AWS-I-169 | monomer | 100 | 11×NAG; 1×EPE; 1×0LJ; | |||
| Crystal structure of clade A/E 93TH057 HIV-1 gp120 core in complex with DMJ-I-228 | monomer | 100 | 11×NAG; 1×EPE; 1×0LK; | |||
| Crystal structure of unliganded HIV-1 clade A/E strain 93TH057 gp120 core | monomer | 100 | 10×NAG; 1×EPE; | |||
| Crystal structure of clade A/E 93TH057 HIV-1 gp120 core in complex with TS-II-224 | monomer | 100 | 11×NAG; 1×EPE; 1×0LM; | |||
| Crystal structure of clade A/E 93TH057 HIV-1 gp120 H375S core in complex with DMJ-II-121 | monomer | 100 | 1×1C1; 1×EPE; 8×NAG; | |||
2 SWISS-MODEL models
| Template | Oligo-state | QMEAN | Range | Ligands | Trg-Tpl Seq id (%) | |
|---|---|---|---|---|---|---|
| 8eu8.1.A | homo-3-mer | 0.65 | 72.36 | |||
| 7n6u.1.A | homo-3-mer | 0.57 | 2×NAG; | 74.79 | ||